Immunomudulatory effects of hydroalcoholic extract of Hypericum perforatum

Document Type : Original Research Article


1 Assistant professor of Immunology, Department of Microbiology Veterinary Medicine Faculty, Urmia University, Urmia, Iran

2 MSc Student of Immunology, Department of Microbiology, Veterinary Faculty, Urmia University, Urmia, Iran

3 Student of Veterinary Medicine, Veterinary Faculty, Urmia University, Urmia, Iran.


Objective: Hypericum perforatum (St. John's Wort) has long been used in traditional medicine to treat a variety of internal and external ailments. The present study was done to evaluate the immumodulatory potentials of the hydroalcoholic extract of H. perforatum.
Materials and Methods: Twenty male BALB/c-mice were randomly allocated in two equal groups and immunized with sheep red blood cells (SRBCs) and complete Freund’s adjuvant. Mice in the treatment group orally received hydroalcoholic extract of H. perforatum (110 mg/Kg daily) from the beginning of the study  which continued for 2 weeks.
Results: The data indicated a significant increase in the level of anti-SRBC antibody and simultaneously a significant decrease in the level of cellular immunity, an enhancement in foot pad thickness, in treatment group compared to control group. The level of the respiratory burst in phagocytic cells and the level of lymphocyte proliferation in splenocytes were significantly decreased in the treatment group compared to control group. Moreover, extract caused a significant reduction in the production of pro-inflammatory IL-17 as well as IFN-γ, parallel to increasing the level of IL-6.
Conclusions: The hydroalcoholicextract of H. perforatum may be used as a natural source for treatment of immunopathologic conditions.


Main Subjects

Aranami T,Yamamura T . 2008. Th17 cells and autoimmune encephalomyelitis (eae/ms). Allergol Int, 57: 115-120.
Asgary S, Solhpour A, Parkhideh S, Madani H, Mahzouni P, Kabiri N . 2012. Effect of hydroalcoholic extract of hypericum perforatum on selected traditional and novel biochemical factors of cardiovascular diseases and atherosclerotic lesions in hypercholesterolemic rabbits: A comparison between the extract and lovastatin. J Pharm Bioallied Sci, 4: 212-218.
Berk M, Williams LJ, Jacka FN, O'neil A, Pasco JA, Moylan S, Allen NB, Stuart AL, Hayley AC, Byrne ML, Maes M. 2013. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med, 11: 200.
Birt DF, Widrlechner MP, Hammer KD, Hillwig ML, Wei J, Kraus GA, Murphy PA, Mccoy J, Wurtele ES, Neighbors JD, Wiemer DF, Maury WJ, Price JP . 2009. Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents. Pharm Biol, 47: 774-782.
Cecchini C, Cresci A, Coman MM, Ricciutelli M, Sagratini G, Vittori S, Lucarini D, Maggi F. 2007. Antimicrobial activity of seven hypericum entities from central italy. Planta Med, 73: 564-566.
Dong C. 2009. Mouse th17 cells: Current understanding of their generation and regulation. Eur J Immunol, 39: 640-644.
Dwyer AV, Whitten DL, Hawrelak JA. 2011. Herbal medicines, other than st. John's wort, in the treatment of depression: A systematic review. Altern Med Rev, 16: 40-49.
El-Behi M,Rostami A,Ciric B. 2010. Current views on the roles of th1 and th17 cells in experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol, 5: 189-197.
Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH. 2010. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol, 162: 1-11.
Jiang W, Liu Y, Love J, Zheng H, Zheng Y, Xu H, Lu H. 2012. Immune regulation of avian influenza vaccine in hens using Hypericum perforatum L. methanol extraction . POJ, 1: 40-45.
Hamaliaka A, Novikova I. 2010. Nitric oxide production disorders in leukocytes of patients with recurrent furunculosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 154: 163-167.
Huang N, Rizshsky L, Hauck CC, Nikolau BJ, Murphy PA, Birt DF. 2012. The inhibition of lipopolysaccharide-induced macrophage inflammation by 4 compounds in hypericum perforatum extract is partially dependent on the activation of socs3. Phytochemistry, 76: 106-116.
Huang N, Singh N, Yoon K, Loiacono CM, Kohut ML, Birt DF. 2013. The immuno-regulatory impact of orally-administered hypericum perforatum extract on balb/c mice inoculated with h1n1 influenza a virus. PLoS One, 8: e76491.
Kim JW, Kim YK, Hwang JA,Yoon HK,Ko YH,Han C, Lee HJ, Ham BJ, Lee HS .2013. Plasma levels of il-23 and il-17 before and after antidepressant treatment in patients with major depressive disorder. Psychiatry Investig, 10: 294-299.
Kobayashi K, Kaneda K, Kasama T. 2001. Immunopathogenesis of delayed-type hypersensitivity. Microsc Res Tech, 53: 241-245.
Korn T, Oukka M, Kuchroo V, Bettelli E. 2007. Th17 cells: Effector t cells with inflammatory properties. Semin Immunol, 19: 362-371.
Kraus B, Wolff H, Elstner EF, Heilmann J. 2010. Hyperforin is a modulator of inducible nitric oxide synthase and phagocytosis in microglia and macrophages. Naunyn Schmiedebergs Arch Pharmacol, 381: 541-553.
Kuerten S, Lehmann PV. 2011. The immune pathogenesis of experimental autoimmune encephalomyelitis: Lessons learned for multiple sclerosis? J Interferon Cytokine Res, 31: 907-916.
Kumar V, Mdzinarishvili A, Kiewert C, Abbruscato T, Bickel U, Van Der Schyf CJ, Klein J. 2006. Nmda receptor-antagonistic properties of hyperforin, a constituent of st. John's wort. J Pharmacol Sci, 102: 47-54.
Mitra Mazumder P, Pattnayak S, Parvani H, Sasmal D, Rathinavelusamy P. 2012. Evaluation of immunomodulatory activity of glycyrhiza glabra l roots in combination with zing. Asian Pacific Journal of Tropical Biomedicine, 2: S15-S20.
Müller J, Alföldy P, Lemmel E-M. 1981. Nitroblue-tetrazolium test for the functional evaluation of phagocytic cells: A critical analysis of the methodology. Agents and Actions, 11: 384-390.
Munzer A, Sack U, Mergl R, Schonherr J, Petersein C, Bartsch S, Kirkby KC, Bauer K, Himmerich H. 2013. Impact of antidepressants on cytokine production of depressed patients in vitro. Toxins (Basel), 5: 2227-2240.
Murdaca G, Colombo BM, Puppo F. 2011. The role of th17 lymphocytes in the autoimmune and chronic inflammatory diseases. Intern Emerg Med, 6: 487-495.
Nabi AH, Islam LN, Rahman MM, Biswas KB. 2005. Polymorphonuclear neutrophil dysfunctions in streptozotocin-induced type 1 diabetic rats. J Biochem Mol Biol, 38: 661-667.
Nathan PJ. 2001. Hypericum perforatum (st john's wort. A non-selective reuptake inhibitor? A review of the recent advances in its pharmacology. J Psychopharmacol, 15: 47-54.
Reuter J, Huyke C, Scheuvens H, Ploch M, Neumann K, Jakob T, Schempp CM. 2008. Skin tolerance of a new bath oil containing st. John's wort extract. Skin Pharmacol Physiol, 21: 306-311.
Visavadiya NP, Soni B, Dalwadi N. 2009. Evaluation of antioxidant and anti-atherogenic properties of glycyrrhiza glabra root using in vitro models. Int J Food Sci Nutr, 60 Suppl 2: 135-149.
Wentworth JM, Agostini M, Love J, Schwabe JW, Chatterjee VK. 2000. St john's wort, a herbal antidepressant, activates the steroid x receptor. J Endocrinol, 166: R11-16.
Wentworth P Jr., Nieva J, Takeuchi C,Galve R, Wentworth AD, Dilley RB, Delaria GA, Saven A, Babior BM, Janda KD, Eschenmoser A, Lerner RA. 2003. Evidence for ozone formation in human atherosclerotic arteries. Science, 302: 1053-1056.